The GL261-APOBEC3B ACTIVE /anti-PD1 vaccine doubled median survival, although when controlling for multiple comparisons this did not reach statistical significance compared to untreated controls ( p = 0.076 Log-Rank test with Holm–Bonferroni correction for multiple comparisons).
← all excerpts
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.
1
0.0760
0.0760